Capecitabine mitigates cardiac allograft rejection via inhibition of TYMS-Mediated Th1 differentiation in mice.
Kong D, Wang Z, Wang H, Yang R, Zhang W, Cao L, Nian Y, Ren J, Lu J, Chen T, Duan J, Song Z, Liu T, Hou W, Yoshida S, Shen Z, Bromberg JS, Zheng H.
Kong D, et al. Among authors: shen z.
Int Immunopharmacol. 2024 Nov 15;141:112955. doi: 10.1016/j.intimp.2024.112955. Epub 2024 Aug 20.
Int Immunopharmacol. 2024.
PMID: 39163685